TerrAscend Stock
TerrAscend Corp.
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Canada
- CEO
- Ziad Ghanem
- Employees
- 933
- Market cap
- $207 M
- IPO
- 03/05/2017
TerrAscend Corp. operates as a comprehensive cannabis enterprise, engaging in the cultivation, processing, and distribution of cannabis products for both medical and regulated adult recreational markets across Canada and the United States. In addition to its core cannabis operations, the firm also develops and…
TerrAscend stock: price history
1D
-4.3%
1W
-7.6%
1M
-26.4%
6M
-24.7%
YTD
-32.3%
1Y
-39.6%
2Y
-58.9%
5Y
-90.9%
10Y
–
Next earnings date
Next earnings date
12/11/2026 (in 26 days)
Volatility around earnings
~37% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 14/10/26. Not a buy or sell signal.Beta
What does this mean?
Double top
BearishThe price failed at a similar high twice, with a pullback in between. This M-shaped pattern is a classic reversal signal from an uptrend into a downtrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about TerrAscend
Analyst assessment of TerrAscend
0
STRONG BUY
1
BUY
2
HOLD
0
SELL
0
STRONG SELL
3
TOTAL · Hold
As of: 28/10/2022
TerrAscend stock metrics
P/E
-3.66
P/B
1.84
EV/EBITDA
5.68
RETURN ON EQUITY
-11.2%
NET MARGIN
-13.6%
DEBT/EQUITY
3.06
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
94.5%
FLOAT SHARES
292,086,606
AVG. DAILY VOLUME (30D)
204,672
Comparable stocks
Frequently asked questions about TerrAscend stock
What does TerrAscend do?
TerrAscend Corp. is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in Canada.
The CEO is Ziad Ghanem, the company employs around 933 people.
The IPO was on 03/05/2017; the stock trades on TSX under the ticker TSND.TO.
What do analysts say about TerrAscend stock?
3 analysts rate the stock, the consensus is Hold (as of 28/10/2022).
This is an external assessment, not a statement by Market Jury.
When does TerrAscend report next?
The next earnings date is 12/11/2026.
Around past earnings, price swings were roughly 37% stronger than usual.
Does TerrAscend pay a dividend?
No, TerrAscend currently does not pay a dividend.
Which stocks are comparable to TerrAscend?
Comparable stocks include Merck, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Zoetis, Sandoz Group, Viatris, Lantheus Holdings and Amneal Pharmaceuticals.
How can I get TerrAscend stock analyzed?
Clicking "Analyze stock" lets five strategies assess TerrAscend against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.